By far, men garner most coveted speaking slots at virology meetings

June 23, 2017

MADISON, Wisconsin - Ann Palmenberg and Rob Kalejta heard complaints at one too many virology conferences about the perceived lack of women among the invited and keynote speakers. So, they did what all good scientists do: They tracked down the data.

In their recent study, published in the Journal of Virology, the University of Wisconsin-Madison researchers examined 35 years worth of invited speaker rosters from four prominent virology meetings, including the American Society for Virology, which is hosting its annual meeting in Madison, Wisconsin starting June 24, 2017. They found that men were overwhelmingly represented. For example, between 1982 and 2017, 77 percent of the speakers at ASV's annual meetings were male.

"We can no longer wonder if this is a problem," says Kalejta, professor of oncology and molecular virology. "The answer is yes and it's happening year after year."

Their findings are emblematic of problems identified in other scientific arenas. For instance, both the European Society for Evolutionary Biology and the American Society for Microbiology (ASM) have conducted similar, though less thorough analyses of their annual meetings and there is a growing body of data to back up perceptions of gender bias in a number of scientific fields. Most scientists are also aware of the "leaky pipeline" problem, where women are trained in the sciences in numbers equal to or outpacing men but fewer go on to hold lucrative faculty positions.

"Being an invited speaker carries career relevance," says Palmenberg, professor of biochemistry and molecular virology. "It's important for (faculty) tenure and to advance a career. Careers can live or die based on whether you're on these lists."

Using official programs for each of the four meetings - ASV, the International Herpesvirus Workshop (IHW), the Positive-Strand RNA Virus Symposium (PSR) and the Gordon Research Conference on Viruses and Cells (GRC) -- as well as personal knowledge of scientists in the field, Kalejta and Palmenberg assembled a gender-matched list of all 4,026 invited speakers over the study time period. They have made the searchable dataset available through the UW-Madison Institute for Molecular Virology website: http://virology.wisc.edu/acp/Women/women.html.

They found that, in general, parity among invited speakers lists has improved across all four of the meetings they studied. For example, in 1982 and 1987, no women were invited as speakers at ASV's annual meetings. But in 2017, 53 percent of invited speakers are female.

"Things are getting better, but they're getting better slowly," says Kalejta. "We need to and can accelerate that."

Additionally, Palmenberg and Kalejta found that when at least one woman was included in the speaker selection process, the number of female speakers increased dramatically. For instance, in years in which the ASV's president was male, averaged across all 35 years, 19 percent of invited speakers at the organization's annual meetings were women. But when the ASV president was a woman, meetings averaged 31 percent female speakers. They observed similar trends for the other three meetings.

Jo Handelsman, professor of plant pathology at UW-Madison and director of the Wisconsin Institute of Discovery, who was not involved in the study, has spent her career researching and working toward gender equity in STEM fields. In 2014, she co-authored a study of scientific symposia speakers at two ASM meetings and also found that having at least one female convener was highly correlated with the number of women who spoke in the session.

Those results have been used to change the process for speaker selection at ASM.

"After sharing this finding with their program planning committee, at the next annual meeting, 48 percent of the speakers were women," Handelsman says. "In one year, they remedied the problem by simply making the organizers aware of the data. ASV could try a similar intervention, particularly in light of this new data."

Indeed, Palmenberg says their data has already made a difference. After she shared them with a male colleague organizing an upcoming virology meeting, he realized that his planned invited speakers list lacked adequate female representation.

"My colleague ran down his list and decided to aim for 50/50," she says. "It's this concept of male organizers picking male speakers and the entire roster is old boys filling in the blanks with their friends."

Both she and Kalejta are quick to emphasize that the onus of achieving parity, or equity, should not be on the organizers alone, though organizers should be willing to put in the work necessary to achieve it. They hope their findings encourage others to be proactive in stepping up as speakers or making recommendations to meeting organizers of colleagues they believe should be considered.

"There are a lot of hidden gems out there," Palmenberg says.

She and Kalejta also do not have an answer to the question of whether meetings should work to achieve equal gender balance among invited speakers or whether they should aim to match the gender demographics of the meeting or the pool of scientists in virology.

"If only 35 percent of PIs in virology are female, should it be 65/35?" Kalejta asks. "If we want to promote women in science, perhaps we should show female graduate students and postdocs that you too can do this. Maybe we should aim higher."

He takes the findings of the study personally. He trains many female graduate students and it bothers him to know that their careers could be negatively affected by biases that do not reflect the quality of their work.

"As much as this is a retrospective analysis, we want it to be used proactively," says Kalejta. "Now we know the past, so we don't have to repeat it."
-end-
Kelly April Tyrrell, kelly.tyrrell@wisc.edu, 608-262-9772

University of Wisconsin-Madison

Related Virology Articles from Brightsurf:

Antiviral used to treat cat coronavirus also works against SARS-CoV-2
Researchers at the University of Alberta are preparing to launch clinical trials of a drug used to cure a deadly disease caused by a coronavirus in cats that they expect will also be effective as a treatment for humans against COVID-19.

Rapid test for the determination of antibodies against Sars-Cov-2
To determine immunity to Sars-Cov-2 and the effectiveness of potential vaccines, the amount of neutralising antibodies in the blood of recovered or vaccinated individuals must be determined.

HIV-1 viral cores enter the nucleus collectively through the nuclear endocytosis-like pathway
How HIV-1 viral cores enter the nucleus through the undersized nuclear pore remains mysterious.

Herpes virus decoded
The genome of the herpes simplex virus 1 was decoded using new methods.

Researchers discover new portal of entry for influenza viruses
Influenza viruses from bats use an entirely different portal to enter the cell than all previously known types of influenza / human cells also infectable in the lab / publication in Nature.

Mobile, instant diagnosis of viruses
In a first for plant virology, a team from CIRAD recently used nanopore technology to sequence the entire genomes of two yam RNA viruses.

Institute of human virology researchers discover bacterial protein that promotes cancer
The Institute of Human Virology (IHV) at the University of Maryland School of Medicine (UMSOM) announced today the discovery that DnaK, a protein of the bacterium mycoplasma, interferes with the mycoplasma-infected cell's ability to respond to and repair DNA damage, a known origin of cancer.

New knowledge on how HIV beats the body's early immune response
In an important step towards eradicating HIV-associated viral reservoirs, researchers at Sydney's Westmead Institute for Medical Research have identified how the HIV virus hijacks the innate immune system to facilitate its replication and spread, thus gaining a foothold infection in the body.

By far, men garner most coveted speaking slots at virology meetings
In their recent study, published in the Journal of Virology, the University of Wisconsin-Madison researchers examined 35 years worth of invited speaker rosters from four prominent virology meetings, including the American Society for Virology, which is hosting its annual meeting in Madison, Wisconsin starting June 24, 2017.

Highlighting the clinical complications associated with ART in HIV/TB coinfected patients
Today Future Science Group announces the publication of an article in Future Virology highlighting the clinical complications associated with antiretroviral therapy in Chinese HIV/ Tuberculosis (TB) coinfected patients.

Read More: Virology News and Virology Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.